(MedPage Today) — The treatment pipeline for generalized myasthenia gravis (gMG) continues to be active, a consequence of the ongoing progress in knowledge that led to approval of six new drugs for the disease.
In recent years, the FDA has approved…
Source link : https://www.medpagetoday.com/spotlight/gmg/116432
Author :
Publish date : 2025-07-09 17:57:00
Copyright for syndicated content belongs to the linked Source.
